Xarelto side effects can be deadly and require immediate hospital care. Rivaroxaban is a Novel Oral Anticoagulant (NOAC) marketed in the US by Bayer and Janssen with the brand name Xarelto (BAY 59-7939). It was the first direct Factor Xa inhibitor that could be taken orally when it was launched in 2008.
Factor Xa Inhibitors : Dosing, Uses, Side Effects , Interactions, Patient Handouts, Pricing and more from Medscape Reference, How Factor Xa Inhibitors . Factor Xa inhibitors work by focusing on and reversing the activity of the clotting factor Xa , thus preventing the formation of blood clots. This group of medications affects the factor Xa within the blood as well as blood in the pre-existing clot. However, it does not affect the platelet aggregation.
All Factor Xa inhibitors Drugs that increase the risk of bleed ing – drugs that inhibit coagulation may increase the risk of bleeding when taken with Factor Xa inhibitors Drugs that may increase the risk of bleeding include: Anagrelide (Agrylin®) Aspirin Direct thrombin inhibitors (dabigatran) Factor Xa inhibitors (e.g. rivaroxaban, apixaban), Factor Xa inhibitors are a type of anticoagulant that work by selectively and reversibly blocking the activity of clotting factor Xa, preventing clot formation. They affect both factor Xa within the blood and within a preexisting clot. They do not affect platelet aggregation.
